Profile
Michael J.
Dawson is currently the Chief of Staff at Centinela Hospital Medical Center.
Previously, he served as the Chief Medical Officer at Leading Biosciences, Inc. and Palisade Bio, Inc. from 2021 to 2022.
He holds a doctorate degree from the University of Southern California and a graduate degree from the University of California San Diego.
Michael Dawson active positions
| Companies | Position | Start |
|---|---|---|
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Human Resources Officer | - |
Former positions of Michael Dawson
| Companies | Position | End |
|---|---|---|
| PALISADE BIO, INC. | Chief Tech/Sci/R&D Officer | 11/10/2022 |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Chief Tech/Sci/R&D Officer | - |
Training of Michael Dawson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Health Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
- Stock Market
- Insiders
- Michael Dawson
















